Zoll Medical gets attention from Wall Street

Investors are starting to notice S&P 600 stocks that are projected to have double-digit increases in sales and earnings.

By Jim Van Meerten Aug 1, 2011 1:55PM

A stock that has received recent notice on Wall Street is Zoll Medical (Zoll) which designs, manufactures and markets an integrated line of proprietary, noninvasive cardiac resuscitation devices, external pacemaker/defibrillators, disposable electrodes, mobile ECG Systems and EMS data management solutions.  The recent price momentum has been a result of upgrades in the projections for sales and earnings.


Barchart technical indicators of recent price momentum:

  • 100% Barchart technical buy signals
  • Trend Spotter buy signals
  • Above it's 20, 50 and 100 day moving averages
  • 4 new highs and up 20.06% in the last month
  • Relative Strength Index is 74.72% and rising
  • Trades around 69.00 which is above its 50 day moving average of 57.45
  • Barchart calculates a 61.99 support level
Fundamental factors to consider:
  • Wall Street brokerage analysts have recently discovered this S&P 600 stock and released 6 strong buy, 1 buy and 1 hold recommendations to their clients based on double digit projections for sales and earnings increases
  • Sales are projected to increase by 14.20% this year and another 15.30% next year
  • Earnings are forecast to increase by 46.00% this year, 37.00% next year and continue to increase by 32.50% annually for the next 5 years

Chart and data provided by Barchart


Summary:  Whether you like large or small cap stocks your portfolio should prosper if it contains stocks having double digit projections for sales and earnings increases.  Zoll Medical (ZOLL) has products that are increasingly popular with both EMTs and emergency rooms across the US.  Europe and Asia are beginning to buy their products so growth in sales looks secure.  Good products, aggressive sales and earning forecasts, recent interest by both professional and individual investors means that this stock deserves a place on your watch lists.
 
Jim Van Meerten is a Marketocracy Master.

0Comments

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

STOCK SCOUTER

StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

126
126 rated 1
286
286 rated 2
474
474 rated 3
680
680 rated 4
626
626 rated 5
609
609 rated 6
620
620 rated 7
462
462 rated 8
304
304 rated 9
132
132 rated 10
12345678910

Top Picks

SYMBOLNAMERATING
AAPLAPPLE Inc10
BIDUBAIDU Inc10
BXTHE BLACKSTONE GROUP L.P10
CELGCELGENE CORP10
FOXATWENTY-FIRST CENTURY FOX Inc CLASS A10
More

VIDEO ON MSN MONEY

ABOUT

Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.